WHAT TO EXPECT?
Be at the forefront of cutting-edge techniques and innovation in urology and robotic surgery. Prostate, Kidney and Bladder Cancer along with Basic Science talks and presentations, live surgeries, 3D video presentations, and more. Join us in New York City from December 8th to 10th, 2023. A long line up of over 80 speakers, many of whom are giants in the field, providing you with a unique opportunity to learn from and connect with them. Save a spot NOW.
World Renowned Speakers
We are extremely excited to showcase the lineup of over 80 internationally renowned speakers. Giants in the field of urology and robotic surgery covering topics across prostate, kidney and bladder cancer and basic science research. Watch the space for a full lineup of speakers coming soon.
Ashutosh Tewari
MBBS, MCh, FRCS (Hon.)
Chair, Department of Urology
Icahn School of Medicine at
Mount Sinai
Ketan Badani
MD, FRCS (Hon.)
Vice Chair, Department of Urology and Director of Robotic Operations
Icahn School of Medicine at
Mount Sinai Hospital
Peter Wiklund
MD, PhD
Director of Bladder Cancer Program Icahn School of Medicine at
Mount Sinai
Watch the space for
a full line up of speakers
coming soon.
Kyrollis Attalla
MD
Assistant Professor
Icahn School of Medicine at Mount Sinai
Aditya Bagrodia
MD
Urologic Oncologist Associate Professor of Urology Disease
UC San Diego Health
Thomas Bessede
MD, PhD
Professor
Paris-Saclay University
Swati Bhardwaj
MD
Chief Resident, Department of Pathology, Molecular and Cell Based Medicine at Icahn School of Medicine at Mount Sinai
Peter Black
MD
Professor, Department of Urologic Sciences University of British Columbia
Aldo M. Bocciardi
MD
Chief of the Urology Unit
Ospedale Niguarda Ca' Granda
Bernard Bochner
MD, FACS
Surgeon, Sir Murray F. Brennan Endowed Chair in Surgery at Memorial Sloan Kettering Cancer Center
Maurizio Buscarini
MD, PhD
Professor
Department of Urology at Mount Sinai
Umberto Capitanio
MD
Urologist
Università Vita-Salute San Raffaele
Goutam Chakraborty
phd
Assistant Professor Department of Urology at Mount Sinai
Dimple Chakravarty
PhD
Assistant Professor Department of Urology at Mount Sinai
Jonathan A. Coleman
MD
Urologic Surgeon at Memorial Sloan Kettering Cancer Center
Simone Crivellaro
MD
Associate Professor in Minimally Invasive Urology
University of Illinois, Chicago
Siamak Daneshmand
MD
Director of Urologic Oncology at USC
Gary E. Deng
MD, phd
Medical Director of Integrative Medicine
Memorial Sloan Kettering Cancer Center
Navneet Dogra
phd
Assistant Professor
Icahn School of Medicine at Mount Sinai
Munir Ghesani
MD
System Chief of Nuclear Medicine
at Mount Sinai Health
Michael Gorin
MD
Associate Professor  Department of Urology at the Icahn School of Medicine
A. Ari Hakimi
MD
Associate Professor at Memorial Sloan Kettering Cancer Center
Ashok Hemal
MD, MCh, FACS, FRCS
Professor of Urology at Wake Forest Baptist Medical Center
Markus Hohenfellner
Md, PhD
Chairman
University Hospital Heidelberg Department of Urology
Jihad Kaouk
MD
Director of Robotic Surgery, Vice chair Surgical Operations
Cleveland Clinic
Isaac Yi Kim
MD, PhD, MBA
Professor and Chair, Department of Urology at Yale School of Medicine
Laurence Klotz
MD, FRCSC
 Professor of Surgery at the University of Toronto
Anant Kumar
MD, MBBS, MS, MCh
Chairman of Uro-Oncology, Robotic & Kidney Transplantation at Max Super Specialty Hospital
Natasha Kyprianou
MBBS, PhD
Professor of Urology and Oncological Sciences at Icahn School of Medicine at
Mount Sinai
Jaime Landman
Md
Professor and Chairman at UC Irvine
Bobby Liaw
MD
Assistant Professor, Hematology and Medical Oncology at Icahn School of Medicine at Mount Sinai
Stacy Loeb
MD, MSc, PhD (Hon)
Professor of the Department of Urology at NYU Grossman School of Medicine
Alberto Martini
MD
Fellow Department of Urology, UT MD Anderson Cancer Center
Reza Mehrazin
MD
Associate Professor of Urology at Icahn School of Medicine at
Mount Sinai
Mani Menon
MD
Chief of Strategy and Innovation in the Department of Urology of the Mount Sinai Health System
Nihal Mohamed
PHD
Director of Patient Education and Behavioral Research in the Department of Urology at Icahn School of Medicine at
Mount Sinai
Alexandre Mottrie
MD, PhD
CEO
ORSI Academy
William K. Oh
MD
Clinical Professor of Medicine in the Division of Hematology and Medical Oncology at The Tisch Cancer Institute at Mount Sinai
Babu Padanilam
PHD
Professor and Researcher in the Department of Urology at the Icahn School of Medicine at Mount Sinai
Michael A. Palese
MD
Professor & Chair of the Department of Urology at Mount Sinai Beth Israel
Vito Pansadoro
MD
President
Vincenzo Pansadoro Foundation
Athanasios Papatsoris
MD, PHD
Professor of Urology at National & Kapodistrian University of Athens
Adriana M. Pedraza Bermeo
MD
RSMIUO Fellow
Cleveland Clinic
Peter Pinto
MD
Investigator and Faculty Member
Urologic Oncology of the National Cancer Institute, National Institutes of Health
Francesco Porpiglia
MD
Chair of Urology Division
San Luigi Gonzaga Hospital - University of Turin
Sanoj Punnen
MD
Co-Chair of Genitourinary Site Disease Group, Sylvester Comprehensive Cancer Center University of Miami
Rajveer Purohit
MD
Director of Reconstructive Urology and Professor of Urology at The Mount Sinai Hospital
Dmitry Pushkar
MD
 Head of Urology Department at Moscow State University of Medicine and Dentistry
Shirin Razdan
MD
Robotics & Urologic Oncology Fellow at Mount Sinai Hospital
Neal Shore
MD, FACS
Chief Medical Officer, Surgical Oncology and Urology at Genesis Care 
Susan F. Slovin
MD, phd
Professor of Medicine
Memorial Sloan Kettering Cancer Center
Rene Javier Sotelo Noguera
MD
Professor of Urology at University of Southern California
Cora N. Sternberg
MD, FACP
Clinical Director, Englander Institute for Precision Medicine
Weill Cornell Medicine New York-Presbyterian
Michael Stifelman
MD
Chair of Urology at Hackensack University Medical Center
Scott T. Tagawa
MD
Professor of Medicine and Urology at Weill Cornell Medicine New York-Presbyterian
Samir S. Taneja
MD
Director, Division of Urologic Oncology at New York University Langone Medical Center
Che-Kai Tsao
MD
Medical Director of the Ruttenberg Treatment Center at the Mount Sinai Hospital
Burak Ucpinar
MD
 Clinical Fellow, Department of Urology, Icahn School of Medicine at Mount Sinai
Robert J. Valenzuela
MD, FACS
Director of Penile Prosthesis Surgery
Mount Sinai Hospitals
Jack Kevin Vassar
MS, PA-C
Clinically Advanced Physician Associate
Department of Urology at Mount Sinai
Vinayak G. Wagaskar
MD, MBBS, MCH
Assistant Professor
Department of Urology at Mount Sinai
Nikhil Waingankar
MD, MSHP
Associate Professor, Department of Urology at Mount Sinai
Alexandre R. Zlotta
MD, phd, FRCSC
Director of Urologic Oncology, Sinai Health System, Toronto
Laura Zuluaga
MD
Research Fellow Icahn School of Medicine at Mount Sinai
Mohamad E. Allaf
MD
Director, Department of Urology, Johns Hopkins Medicine
Dhyan Chandra
PhD
Professor of Oncology at Roswell Park Comprehensive Cancer Center
Jun Luo
Professor in Urology at the Johns Hopkins School of Medicine
Christopher Saigal 
Md 
Professor and Vice Chair, UCLA Department of Urology  
Richard Ting 
Phd 
CTO, Antelope Surgical Solutions, Inc.
 
Deepak Chopra
MD
Founder at Deepak Chopra LLC
Mariana Figueiro 
 Phd
Icahn School of Medicine at Mount Sinai  
G. Kenneth Haines III
MD
Director
Icahn School of Medicine at Mount Sinai  
Neeraja Tillu 
MBBS, MCh 
Mount Sinai Bladder Cancer Fellowship  
Richard Stock 
MD 
Professor
Icahn School of Medicine at Mount Sinai
Amir Horowitz
 PhD
Assistant Professor
Icahn School of Medicine at Mount Sinai
 
Ping Mu
PhD
Assistant Professor at UT Southwestern Medical Center
Asher Mandel
 MD
Associate Researcher
Icahn School of Medicine at Mount Sinai  
Manish Choudhary
MBBS, MCh
Mount Sinai
Prostate Cancer Fellowship
Murilo Luz
MD
Urologic Oncologist
Beneficência Portuguesa de São Paulo
Ricardo R. Gonzalez
MD 
Associate Professor
Houston Methodist Academic Institute
Wei Yang
 PhD
Associate Professor
Stony Brook University
 
Neil Rofsky
MD
Professor and Chair of Diagnostic, Molecular and Interventional Radiology at the Mount Sinai
Carl Wijburg
 MD
Board Member
European Association of Urology
David Berman
MD, PhD
Head Of Department, Pathology and Molecular Medicine
Queen's University
Roberto Pili
MD
Chief of the Division of Hematology/Oncology in the Department of Medicine University at Buffalo
Hikmat A. Al-Ahmadie
MD 
Associate Attending at Memorial Sloan Kettering Cancer Center
Hooman Djaladat
 MD
Associate Professor at Keck Medicine of USC
 
John Sfakianos
MD
Associate Professor of Urology at Icahn School of Medicine at
Mount Sinai
Benjamin Hopkins
 MD
Medical Director
Surgery Colorectal Informations Operations
Vanderbilt University Adult Hospital
Isuru Jayaratna
MD
Assistant Professor of Urology and Urologic Oncology at the Icahn School of Medicine at Mount Sinai
Rui Farinha
MD
Urology Consultant; Robotic Surgical
Trainer and Scientific Researcher
at ORSI Academy
Stefano Puliatti
MD 
Robotic Surgeon. Co-founder and
RARP lead (Robotic-Assisted Radical Prostatectomy) - iRARP
Ruben De Groote
 MD
Consultant urological surgeon Uro-oncology and Robotics bij Onze Lieve Vrouw Hospital Aalst-Asse-Ninove
 
Don't miss out.
We look forward to seeing you there.
AGENDA
FRIDAY, DECEMBER 8, 2023 - Day 1  |  MAIN SESSION
7:00 AM
Registration and Continental Breakfast
Stern Lobby
7:45 AM
Welcome and Introduction
Ash Tewari, MBBS, MCh; Dennis S. Charney, MD, Dean Icahn School of Medicine
8:00 AM
Celebrating The Life of Alan Partin - Championing The Role of Surgeon - Scientist
Speaker: Mohamad E. Allaf, MD
8:20 AM
SESSION I  |  LIVE CASE #1  |  ROBOT ASSISTED LAPAROSCOPIC PROSTATECTOMY (RALP)
Surgeon: Ash Tewari, MBBS, MCh
Moderator: Ashok Hemal, MD
Panel: Anant Kumar, MBBS, MCh; Alexandre Mottrie, MD, PhD; Vito Pansadoro, MD; Peter Pinto, MD; Francesco Porpiglia, MD
9:30 AM - 9:45 am
BREAK / VISIT EXHIBITS
SESSION II  |  THE OPENING ACT: FROM SCREENING TO DIAGNOSIS TO SURVEILLANCE
Moderator: Ashok Hemal, MD
Panel: Isaac Yi Kim, MD, PhD; Michael Gorin, MD
9:45 AM
Moving Beyond Gleason Grade: What Does the Future Hold?
G. Kenneth Haines III, MD
10:00 AM
The Manogram: Role of MRI in Prostate Cancer Screening
Peter Pinto, MD
10:15 AM
Light and Circadian Rhythms: Implications for Cancer
Mariana Figueiro, PhD
10:30 AM
Use of MRI in Active Surveillance for Prostate Cancer
Samir S. Taneja, MD
10:45 AM
Active Surveillance in 2023: What Have We Learned and Where Can We Do Better?
Laurence Klotz, MD
11:00 AM
Improving the quality of decisions in men with prostate cancer: data driven shared decision making
Christopher Saigal, MD
11:15 AM
Sleep, Nutrition and Physical Activity in Prostate Cancer
Stacy Loeb, MD, MSC, PhD
11:30 AM
Biomarkers and MRI For Prostate Cancer Detection
Sanoj Punnen, MD
11:45 AM
Prostate Cancer Screening Using a Novel Mobile Van-Based Approach:
Can This Redefine the Delivery of Healthcare Equity?
Ashutosh Maheshwari, BA
12:10 Pm - 1:15 pm
LUNCH / VISIT EXHIBITS
SESSION III  |  FROM THEORY TO THERAPY:
NEW INNOVATIONS IN SURGICAL MANAGEMENT FOR PROSTATE CANCER
Moderator: Aditya Bagrodia, MD, FACS, OBE
Panel:  Mohamad E. Allaf, MD; Kyrollis Attalla, MD; Mani Menon, MD; Ash Tewari, MBBS, MCh
1:15 pm
Fluorescence in Prostate Cancer Surgery
Francesco Porpiglia, MD
1:35 pm
Modalities of Focal Therapy and Possible Complications
 Jonathan A. Coleman, MD
1:55 pm
Why Cryotherapy is my Preferred Modality for Prostate Ablation
Michael Gorin, MD
2:15 pm
Spectroscopic Raman Histology for Rapid Real-Time Margin Assessment During Radical Prostatectomy
Samir Taneja, MD
2:35 pm
Management of Localized Prostate Cancer in Renal Transplant Patients [HOLOGRAM]
Alberto Breda, MD
2:55 pm
Considerations in RALP for Urethral Sphincter Nerve Supply
 Thomas Bessede, MD, PhD
3:15 pm - 3:45 Pm
BREAK / VISIT EXHIBITS
 
SESSION IV  |  DEBATES
Moderator: Ketan K. Badani, MD
Panel: Dmitry Pushkar, MD; Maurizio Buscarini, MD, PhD; Peter Wiklund, MD, PhD
3:45 pm
Unilateral vs. Bilateral LND
Alberto Martini, MD vs. Neeraja Tillu, MBBS, MCh
4:05 pm
Retzius-Sparing vs. Hood Technique
Aldo Massimo Bocciardi, MD vs. Vinayak G. Wagaskar, MBBS, MCh
4:25 pm
Single Port vs. Multiport
Jihad Kaouk, MD vs. Ashok Hemal, MD
4:45 pm
Intermediate-Risk Prostate Cancer: Radiation or Surgery
Richard Stock, MD vs. Mani Menon, MD
5:05 pm
Closing Remarks
Ash Tewari, MBBS, MCh
FRIDAY, DECEMBER 8, 2023 - Day 1  |  BREAKOUT SESSIONS
EMERGING FRONTIERS IN PROSTATE CANCER: IMMUNOTHERAPY AND NOVEL BIOMARKERS
Moderator: Natasha Kyprianou, MBBS, PhD
Panel: Babu Padanilam, PhD, Navneet Dogra, PhD
9:45 am
Phenotypic Landscape of CRPC: Emerging Clinical Trials
Natasha Kyprianou, MBBS, PhD
10:00 am
Targeted Immunotherapies for the Treatment of Advanced Prostate Cancer
Susan F. Slovin, MD, PhD
10:15 am
Can We Prevent Treatment Resistance in mCRPC by Rapid Cycling of Therapy? The PRINT Trial
William Oh, MD
10:30 am
Pathology Emerging Novel Biomarkers/Staining Methods
Swati Bhardwaj, MBBS, MD
10:45 am
Autologous Vaccination: Can We Induce Immunity to Prostate Cancer?
Sujit S. Nair, PhD
11:00 am
Novel AI powered tool to accurately identify prostate cancer patients at risk of progression
Dimple Chakravarty, PhD
11:15 am
Y-Chromosome and Prostate Cancer
Goutam Chakraborty, PhD
11:30 am
RETURN TO MAIN SESSION
THE GENETIC BRIDGE: LINKING GENOMIC REVELATIONS TO THERAPEUTIC REVOLUTIONS IN PROSTATE CANCER
Moderator: Amir Horowitz, PhD
Panel: Natasha Kyprianou, MBBS, PhD; Sujit S. Nair, PhD; Babu Padanilam, PhD
1:30 pm
Targeting Mitochondrial Metabolism and Function in Prostate Cancer
Dhyan Chandra, PhD 
1:50pm
Selecting Amongst the Sea of Options in Hormone Naïve Prostate Cancer
Che-Kai Tsao, MD
2:10 pm
The Utility of Early Genomic Classifiers
 Ping Mu, PhD
2:30 pm
PARP-Inhibition in Prostate Cancer
Goutam Chakraborty, PhD
2:50 pm
Next Generation Anti-Androgen Therapy for Metastatic HSPC
Cora N. Sternberg, MD
3:10 pm
Genomics of Liquid Biopsies
Navneet Dogra, PhD
3:30 pm
RETURN TO MAIN SESSION
PATIENT CENTERED Q&A WITH EXPERTS
Moderator: Ash Tewari, MBBS, MCh
Panel: Mani Menon, MD; Asher Mandel, MD, MA; Swati Bhardwaj, MBBS, MD; Manish Choudhary, MBBS, MCh; Christopher Saigal, MD
3:30 pm
Q&A with Experts
4:15 pm
RETURN TO MAIN SESSION
SATURDAY, DECEMBER 9, 2023 -  Day 2  |  MAIN SESSION
7:00 am
Registration and Continental Breakfast
Stern Lobby
7:35 am
Welcome and Introduction
Ash Tewari, MBBS, MCh
7:45 am
LIFETIME ACHIEVEMENT AWARD - Dr. Peter Scardino: A Perspective and Journey of a Legend
Ash Tewari, MBBS, MCh
8:15 am
SESSION I  |  STATE-OF-THE-ART LECTURE: A JOURNEY OF NERVE SPARING, FROM HAMMOCK TO HYDRO
Speaker: Ash Tewari, MBBS, MCh
9:00 am - 9:15 AM
BREAK / VISIT EXHIBITS
SESSION II  |  SEMI-LIVE PROSTATECTOMY TECHNIQUE
Moderator: Peter Wiklund, MD, PhD
Panel: Vito Pansadoro, MD; Ash Tewari, MBBS, MCh; Mani Menon, MD
9:15 am
Precision Prostatectomy
Mani Menon, MD
9:35 am
Retzius-Sparing Prostatectomy: Highlighting the Technique
Aldo Massimo Bocciardi, MD
9:55 am
Robot-Assisted Salvage Prostatectomy
Rene Javier Sotelo, MD
10:15 am
Single Port Transvesical Radical Prostatectomy
Jihad Kaouk, MD
10:35 am
Robotic Radical Prostatectomy: Hugo RAS System
Alexandre Mottrie, MD; PhD
10:55 am
Robot-Assisted Simple Prostatectomy
Ashok Hemal, MD
11:15 am
Retzius-Sparing Trans-Douglass Radical Prostatectomy
Markus Hohenfellner, MD
11:35 am - 12:30 PM
LUNCH  /  VISIT EXHIBITS
12:30 pm
SESSION III  |  LIVE CASE #3  |  KIDNEY  |  PARTIAL NEPHRECTOMY
Surgeon: Ketan K. Badani, MD
Moderators: Kyrollis Attalla MD; Laura Zuluaga, MD
Panel: Simone Crivellaro, MD; Jaime Landman, MD; Michael Stifelman, MD; Ashok Hemal, MD
SESSION IV  |  MANAGEMENT OF ADVANCED PROSTATE CANCER
Moderator: Mani Menon, MD
Panel: Sujit S. Nair, PhD; Murilo Luz, MD
1:30 pm
Careful Preoperative Selection of Patients with Locally Advanced Prostate Cancer Optimizes Outcomes of RALP
Dmitry Pushkar, MD
1:50 pm
Treatment of Castrate-Resistant Prostate Cancer
Neal Shore, MD
2:10 pm
Cytoreductive Prostatectomy (CRP) in Metastatic Prostate Cancer
Isaac Yi Kim, MD, PhD
2:30 pm
Major Breakthroughs in the Science of Healing
Deepak Chopra, MD

2:50 pm
RADICALS-RT: A Review of Early vs. Salvage Radiation in High-Risk Prostate Cancer
Richard Stock, MD
3:10 pm
Can We Avoid Biopsy in PSMA-Positive Lesion and Go Straight to RALP?  [HOLOGRAM]
Declan Murphy, MBBCh
3:30 pm
Prostate Cancer Survivorship: Does surgeon perception of postprostatectomy incontinence affect referral patterns and lead to surgical undertreatment?
Ricardo R. Gonzalez, MD
3:50 pm
Novel Phenotypic Profiling in Advanced Prostate Cancer
Natasha Kyprianou, MBBS, PhD
4:10 pm
Neoadjuvant ADT: who will benefit?
Anant Kumar, MBBS, MCh
4:30 pm - 4:45 PM
BREAK / VISIT EXHIBITS
SESSION V  |  HUMAN EXPERTS VS. AI: WHO CAN SPOT THE SUPERIOR NERVE SPARING?
Moderator: Ash Tewari, MBBS, MCh
Panel: Drishti Gupta, BS; Biplab Mahadani BE; Michael Demeo, ITIL; Vito Pansadoro, MD; Isaac Yi Kim, MD, PhD; Francesco Porpiglia, MD
4:45 pm
Predicting Outcomes, Humans vs. AI

 
5:30 pm
Closing Remarks
Ash Tewari, MBBS, MCh
SATURDAY, DECEMBER 9, 2023  -  Day 2  |  BREAKOUT SESSIONS
NEW PERSPECTIVES: THE FUTURE IS BRIGHT
Moderator: Maurizio Buscarini, MD, PhD
Panel: Adriana M. Pedraza Bermeo, MD
9:15 AM
Integration of Large Language Models in Urologic Care and Research
Michael Gorin, MD
9:35 AM
Racial Disparities in Prostate Cancer
Nihal Mohamed, PhD
9:55 AM
Prostate Cancer in Transgender Women
Rajveer Purohit, MD
10:15 AM
Managing Sexual Dysfunction Following RALP
Robert J. Valenzuela, MD
10:35 AM
A Rare African-ancestry Germline Variant Associated with Aggressive Prostate Cancer
Jun Luo, MD, PhD
10:55 AM
Multi-level Proteomics Reveal RIPK2/MKK7/c-Myc Signaling as a Drug Target in Prostate Cancer Metastasis
Wei Yang, PhD
11:15 AM
What we Eat and How it Matters: Effect of Diet and Lifestyle on Prostate Cancer
Gary E. Deng, MD, PhD
11:35 AM
BREAK/LUNCH/VISIT ABSTRACT SESSION
A LOOK UNDER THE HOOD: EVOLVING IMAGING TECHNOLOGIES
Moderator: Michael Gorin, MD
1:30 pM
Intraoperative Imaging Targets During Prostatectomy
Richard Ting, PhD
1:50 pM
Can We Avoid Pelvic Lymph Node Dissection in Patients With Negative PSMA PET Scan?
Vito Pansadoro, MD
2:10 pM
MRI PIRADS Version 2: Pearls and Pitfalls
Neil Rofsky, MD
2:30 pM
Novel Targets for Molecular Imaging in Prostate Cancer
Munir Ghesani, MD
2:50 pM
Microultrasound as a Biomarker in Prostate Cancer
Adriana M. Pedraza Bermeo, MD
3:10 pM
AI and Microultrasound
Wayne Brisbane, MD
3:30 pM
RETURN TO MAIN SESSION
SUNDAY, DECEMBER 10, 2023  -  Day 3 | MAIN SESSION
7:00 AM
Registration and Continental Breakfast
Stern Lobby
7:35 AM
Welcome and Introduction
Ash Tewari, MBBS, MCh
7:45 AM
Introduction to Cystectomy with Intracorporeal Urinary Diversion
Peter Wiklund, MD, PhD
8:00 AM
SESSION I  | SEMI-LIVE CASE SURGERY: Functional Preservation in Male and Female Cystectomy with Urinary Diversion
Surgeon: Peter Wiklund, MD, PhD
Moderator: Reza Mehrazin, MD
Panel: Bernie Bochner, MD; Sia Daneshmand, MD; John Sfakianos MD, Carl Wijburg MD
SESSION II  |  NONINVASIVE BLADDER CANCER
Moderator: Peter Wiklund, MD, PhD
Panel: John Sfakianos, MD; Peter Black, MD; Alexandre Zlotta, MD
8:45 AM
Early vs. Delayed Cystectomy in High-Risk Non-Muscle Invasive Bladder Cancer
Peter Black, MD
9:05 AM
Disease Progression in Low-Risk Bladder Cancer: Who is at Risk?
Alexandre Zlotta, MD, PhD
9:25 AM
Morphologic and Molecular Classification of Non-muscle Invasive Bladder Cancer
David Berman, MD, PhD
9:45 AM - 10:00 aM
BREAK / VISIT EXHIBITS
 
10:00 aM
STATE-OF-THE-ART LECTURE | Robotic Kidney Surgery: A Journey of 3000 Cases
Ketan K. Badani, MD, FRCS (Hon.)
SESSION III | MANAGEMENT OF KIDNEY CANCER: EXPERT SESSION
Moderator: Burak Ucpinar, MD
Panel: Alexandre Mottrie, MD; Kyrollis Attalla, MD
10:15 aM
Classification of Kidney Tumors: New Approach to the TNM System
Umberto Capitanio, MD
10:35 aM
Long-Term Functional Outcomes in Robotic Partial Nephrectomy
Jihad Kaouk, MD
10:55 aM
Partial Nephrectomy for Complex Tumors: Tips and Tricks
Ashok Hemal, MD
11:15 aM
Targeting Tumor Metabolism in RCC
Roberto Pili, MD
11:35 aM
Current State of Kidney Biopsy and Tumor Ablation
 Jaime Landman, MD
11:55 aM
Single Port Robotic Surgery for Kidney Tumors
 Simone Crivellaro, MD
SESSION IV  |  IS SMALLER BETTER?
DEBATING THE MERITS OF SINGLE PORT ROBOTIC KIDNEY SURGERY
Moderator: Reza Mehrazin, MD
Panel: Reza Mehrazin, MD;  Ashok Hemal, MD
12:15 PM
Single Port Surgery
For: Michael Stifelman, MD
Against: Alexandre Mottrie, MD
12:35 PM
Q&A
12:45 PM - 1:30 PM
LUNCH / VISIT EXHIBITS
SESSION V  |  MUSCLE-INVASIVE BLADDER CANCER
Moderator: Ashok Hemal, MD
Panel: Nikhil Waingankar, MD; Neeraja Tillu, MBBS, MCh
1:30 PM
Nerve-Sparing Radical Cystectomy: Male
Carl Wijburg, MD
1:50 PM
Intracorporeal Radical Cystectomy: Lessons Learned from the iRoc Trial
Nikhil Vasdev, MBBS, MRCS, Dsc
2:10 PM
ctDNA as a Biomarker in Invasive Bladder Cancer
 John Sfakianos, MD
2:30 PM
Approaches to Bladder Sparing: What Have We Learned?
Alexandre Zlotta, MD, PhD
2:50 PM
How Do We Approach Variant Histologies in Invasive Bladder Cancer?
Hikmat A. Al-Ahmadie, MD
3:10 PM
Single Port Robotic Urinary Diversion
Reza Mehrazin, MD
SESSION VI  |  WHAT IS THE ROLE OF LYMPH NODE DISSECTION IN INVASIVE BLADDER CANCER: DEBATE
Peter Wiklund, MD, PhD
3:30 PM
Limited Node Dissection
Siamak Daneshmand, MD
3:40 PM
Extended Node Dissection
Bernard H. Bochner, MD
3:50 PM
Q&A / DISCUSSION
4:00 PM - 4:20 PM
BREAK / VISIT EXHIBITS
 
SESSION VII  |  TESTES
Moderator: John Sfakianos, MD
4:20 PM
Updated Indications for RPLND: SEMS Trial
Siamak Daneshmand, MD
4:40 PM
Robotic RPLND
Hooman Djaladat, MD
5:00 PM
Optimal Templates
Aditya Bagrodia, MD
5:20 PM
Closing Remarks
Peter Wiklund, MD, PhD
SUNDAY, DECEMBER 10, 2023 - Day 3  |  BREAKOUT SESSIONS
KIDNEY & PENILE CANCER
Moderators: Shirin Razdan, MD; Jack Kevin Vassar, PA-C
Panelists: A. Ari Hakimi, MD
10:30 AM
Current Role for Immunotherapy for Kidney Cancer and Ongoing Clinical Trials
Bobby Liaw, MD
10:45 AM
Rapid Assessment of Patient Drug Sensitivity (RaPiDS) in the Assessment of Kidney Cancer Treatment Response: Current Status and Future Directions
Benjamin Hopkins, MD
11:00 AM
Updates on Groin Dissection for Penile Cancer and Minimally invasive groin dissection
Kyrollis Attalla, MD
11:30 aM
RETURN TO MAIN SESSION
SEEING INTO THE FUTURE: ADVANCES IN IMAGING OF RENAL MASSES
Moderator: Michael Gorin, MD
Panelists: Isuru Jayaratna, MD; Maurizio Buscarini, MD, PhD
1:30 PM
3-D Imaging in Robotic Surgery: Evaluation of Surgeons’ Perceptions
Francesco Porpiglia, MD
1:50 PM
Sestamibi Renal Scan’s Importance in Clinical Decision Making for Differentiating Renal Oncocytoma and RCC
Michael Gorin, MD
2:10 PM
New Technology for the Treatment of Kidney Tumors
Ketan K. Badani, MD
2:30 PM
Carbonic Anhydrase 9: Targeted Imaging for Renal Cell Carcinoma:
What’s the Current Role in Diagnosis?
Munir Ghesani, MD
2:50 PM
Role of Artificial Intelligence and Digital Imaging in Pathological Evaluation of RCC: Where Do We Stand?
Kenneth Haines III, MD
3:10 PM
RETURN TO MAIN SESSION
 
Conference Location
 The Mount Sinai Hospital
Annenberg Building / Guggenheim Pavilion
100th Street & 5th Avenue
New York, NY 10029
HOTEL ACCOMMODATIONS
You are responsible for making your hotel room reservations for your company personnel. Please note that room reservations should be made in advance. Below are a few suggested hotels close to the hospital.
 
Courtyard Marriott New York Manhattan / Upper East Side
410 E 92nd St, New York, NY 10128
 
The Franklin New York
164 East 87th Street, New York, New York 10128
Sponsors
Get in touch with us for sponsorship information.
Email us at:
 [email protected]

Download the 2023 MS Urology Prospectus Here!
EXHIBIT HOURS
Friday, December 8    
8:00 am – 11:00 am Exhibit Set-up
12:00 pm – 5:30 pm Exhibits Open
 
Saturday, December 9
7:00 am – 6:00 pm Exhibits Open
 
Sunday, December 10
7:00 am – 1:30 pm Exhibits Open
1:30 pm – 4:00 pm Exhibit Dismantle


EXPO SERVICE / SHIPPING OF MATERIALS
Due to regulations at The Mount Sinai Hospital and limitations for unloading trucks, it is highly recommended that you ship your exhibit materials Advance To Warehouse. For companies shipping larger exhibits with wooden crates or medical equipment, it is MANDATORY to ship your materials Advance To Warehouse. Please download the official service kit below for full details on shipping to Mount Sinai Hospital.
ABSTRACT SUBMISSIONS
The Prostate Cancer and Urologic Oncology Symposium is excited to now be accepting abstract submissions to be displayed on-site during the symposium!

FORMAT / SIZING:
If your abstract is selected, you will be responsible for printing and bringing your poster with you to display onsite at the symposium. Posters will be displayed on a 4’ high x 8’ wide surface, and posters should not exceed this size when printed. Pins to display your poster will be provided.

PRIZES:
Accepted submitters will receive complimentary registration. Posters will be judged and prizes given to the top 3 submitters, as well as acknowledgement at the symposium and the opportunity to be invited to the excusive faculty dinner.

Processing Registration...